Philippe Lucas PhD is a cannabis and psychedelic researcher and President of Sabi Mind, a clinic group focused on increasing access to psychedelic-assisted therapy in the treatment of mental health, pain and problematic substance use, and he is also CEO of Plantchek, which produces on-site analytical tools for the cannabis industry. Philippe was founder and Executive Director of the Vancouver Island Compassion Society, one of Canada’s first medical cannabis dispensaries, and a founding Board member of the Multidisciplinary Association of Psychedelic Studies Canada. More recently he worked as VP, Global Patient Research & Access at Tilray, where he oversaw a comprehensive international clinical and observational cannabis research program.